Similarly, targeting neuropilin-1 (NRP1), a transmembrane receptor that contributes to cell contact evasion and tumorigenesis in ovarian tumors, with the miRNA miR-200c, induces sensitization of resistant SKOV3 ovarian cancer cell lines (BRCA wild-type) to olaparib[56]. This evidence concerns the gene NRP1 and ovarian cancer.